What You Should Know:
– Isaac Health, a leading health technology company for brain health and dementia care, announced today a $10.5 million Series A led by Flare Capital Partners, with participation from new investors, Industry Ventures, and Black Opal Ventures.
– Existing investors — Meridian Street Capital, B Capital, and Primetime Partners — also doubled down, with some increasing their stake. This brings the company’s total funding to $16.3 million, enabling it to expand its partnerships and technology, now newly available in all 50 states, advancing its mission to make specialist dementia care more accessible.
Isaac Health Secures Funding to Scale AI-Driven Dementia Care Nationwide
Isaac Health, a scalable platform for brain health and dementia care, partners with leading healthcare organizations to deliver expert screening, assessment, treatment, and care management for people living with dementia and their caregivers. Its mission is to ensure families receive high-quality, specialist care within days—not months.
With over seven million Americans currently living with Alzheimer’s dementia—a figure expected to surpass 12 million by 2025—access to timely care remains a critical challenge. On average, patients face a 36-month wait for appointments, losing valuable opportunities for preventive intervention. Isaac Health’s AI-enabled brain health platform addresses this gap by combining center-of-excellence clinical expertise with scalable digital infrastructure, including patented AI screening capabilities. The platform can detect, diagnose, and manage dementia from home, leveraging predictive machine learning to identify diverse cognitive and brain health conditions and connect patients with specialist teams. This approach has driven measurable results, with 73% of patients experiencing improved neurocognitive function over six months, and 92% meeting cognitive improvement goals within just three weeks.
“Adults over age 65 are the fastest-growing group in the U.S., and with that comes a surge in Alzheimer’s and other dementias,” said Dr. Joel Salinas, Chief Medical Officer and Co-Founder of Isaac Health. “Our health system isn’t equipped for the scale and complexity of these needs—patients face long delays, missed intervention windows, and higher rates of ER visits and hospitalizations. This funding allows Isaac Health to bridge these gaps amid a growing public health crisis.”
Existing investors — Meridian Street Capital, B Capital, and Primetime Partners — also doubled down, with some increasing their stake. This brings Isaac Health’s total funding to $16.3 million, enabling expansion of partnerships and technology, now available in all 50 states, advancing its goal of making specialist dementia care more accessible.
Strategic Growth Priorities
The new capital will accelerate the buildout of Isaac Health’s proprietary technology and nationwide care delivery model, including:
- Virtual care infrastructure and smart care management tools – Supporting patients and caregivers throughout the disease journey to preserve independence, quality of life, and prevent avoidable crises.
- Enhanced AI-driven detection – Enabling earlier and more accurate diagnosis at the population level.
- Predictive clinical decision support systems – Guiding proactive treatment and ongoing care.
- Data and analytics capabilities – Measuring outcomes and optimizing care pathways.
With these advancements, Isaac Health is positioned to deliver timely, technology-enabled dementia care at scale, improving outcomes and accessibility—particularly for underserved populations.
